Superparamagnetic iron oxide nanoparticles (SPIONs), -Fe 2 O 3 , with hydrophilic surfaces are fabricated in ethylene glycol solutions, without surfactant or additive, by solvothermal process from -Fe 2 O 3 nanoparticle as precursors. With the addition of a trace of hydrazine hydrate, the cubic phase Fe 3 O 4 nanoparticles are obtained instead of -Fe 2 O 3 . The saturation magnetization value of -Fe 2 O 3 nanoparticles is up to 74.3 emu/g. This study provides a low cost, safe, and universal route to serve as excellent biocompatibility magnetic core for future applications in biomedical, agriculture, and horticulture applications.
Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) attracted increasing attention due to their promising applications like tissue cryopreservation, magnetic resonance imaging (MRI), immunoassay, biomolecule separation, hyperthermia, and drug delivery [1] [2] [3] [4] . All of these biomedical applications require the nanoparticles to have high magnetization values and hydrophilic surface and also nontoxicity and biocompatibility [5, 6] .
Until now, various wet chemical processes such as coprecipitation, sol-gel, hydrothermal/solvothermal, thermal decomposition, electrochemical strategy, and ultrasonic chemistry have been extensively applied to prepare superparamagnetic nanoparticles [7] [8] [9] [10] . Among these routes, different surfactants, such as oleic acid, are introduced to prevent the aggregation of nanoparticles; also toxic reagents such as Fe(III) glucuronate, Fe(acac) 3 , or Fe(CO) 5 are usually used, which render the surface of as-obtained samples to be nonbiocompatible, and obstructed the further surface modification [4, 8, 11, 12] .
Benefiting from previous study [13] , we find a novel route to synthesize superparamagnetic iron oxide nanoparticles through -Fe 2 O 3 nanoparticles as precursor in this study, only in presence of ethylene glycol, without the presence of any other agents, surfactants, and additives. Herein, nanoscale -Fe 2 O 3 particles were obtained using a smaller particle size of -Fe 2 O 3 as precursors and the mild ethylene glycol as a solvent. This study provides excellent biocompatibility magnetic core for applications in biomedical, agriculture, and horticulture applications.
Experimental
-Fe 2 O 3 precursors were synthesized by the modified solvothermal method as previously reported [13] : 0.273 g of FeCl 3 ⋅6H 2 O (0.1 mmol) was dissolved under vigorous magnetic stirring in ethanol (10.0 mL) and 2 mL of deionized water. Until completely dissolved, 0.6 g of sodium acetate was added while stirring. The mixture was sealed in a Teflonlined stainless-steel autoclave (25 mL) and maintained at 160 ∘ C for 3 h for solvothermal crystallization. -Fe 2 O 3 nanoparticles were synthesized by the following procedure: the samples were washed by distilled water and absolute ethanol then transferred to a Teflon-lined stainless-steel autoclave (25 mL) and sealed after adding 10 mL of ethylene glycol, and solvothermal processing was maintained at 180 ∘ C for 12 h. The resulting products were washed with water and alcohol several times and finally dried in a desiccator at 60 ∘ C for ca. 10 h.
Powder X-ray diffraction (XRD) was characterized by a Rigaku D/MAX 2200 diffractometer. Scanning electron microscopy (SEM) was taken with a FEI Quanta 400. TEM images were prepared on a JEM-2010HR transmission electron microscope. X-ray photoelectron spectra (XPS) were recorded on an ESCALAB 250 spectrometer. The magnetic properties of the samples were measured at 300 K on a Quantum Design MPMS XL-7 SQUID magnetometer.
Results and Discussion
The powder X-ray diffraction patterns (pXRD) of as-prepared -Fe 2 O 3 precursor in Figure 1 (a) match with JCPDS card number 33-0664 for rhombohedral -Fe 2 O 3 with = = 0.5036 nm and = 1.3749 nm, confirming that the product is hematite. The weak peaks of XRD patterns probably foretold a very small crystal size or amorphous state of the final products. Figure 1(b) shows the XPS spectrum of as-prepared nanoparticles. The Fe 2p 3/2 binding energy of 710.9 eV and the corresponding satellite peak at 719.5 eV, a result of charge transfer screening, can be solely attributed to the presence of Fe 3+ of the solid samples, indicating that the as-synthesized sample is composed of -Fe 2 O 3 [14] . From the SEM and TEM image in Figures 1(c) and 1(d) , we could see that the sample consists of nanoparticles with sizes of only less than 3 nm, which are greatly less than -Fe 2 O 3 in our previous work [13] .
Then, the new structure were obtained by adding 10 mL of ethylene glycol into as-prepared -Fe 2 O 3 precursors, and solvothermal processing was maintained at 180 ∘ C for 12 h. The pXRD of as-synthesized typical sample in Figure 2 (a) match well with JCPDS card number 39-1346 for cubicstructure iron oxide with = = = 8.395 nm. However, it is difficult to distinguish the -Fe 2 O 3 and Fe 3 O 4 phases only from the XRD patterns due to their similarity of phase structures. The XPS spectrum is usually an important way to distinguish -Fe 2 O 3 and Fe 3 O 4 phase. The powder samples (Figure 2(b) ) are similar to that of -Fe 2 O 3 precursors, and the satellite peak at 719.6 eV still exists, indicating that the assynthesized sample is composed of -Fe 2 O 3 . The atom ratio of the product is determined as Fe (23.99%) and O (56.54%) using XPS analysis. The oxygen content is higher than that of both Fe 3 O 4 and -Fe 2 O 3 . On one hand, it is probably because oxygen atoms are as the terminal atom layer for iron oxide crystals, which results in a higher oxygen detecting value near the crystals surfaces; on the other hand, the clean surfaces easily adsorb oxygen in the air.
From the TEM image in Figure 2 (c), we can see that the product consists of highly dispersed polyhedral nanoparticles Journal of Nanomaterials show the as-obtained powders with high crystallinity (Figure 2(d) ). In our previous report, the side surface edges -Fe 2 O 3 nanoplates gradually redissolved into nanoparticles through "a mass transformation" during solvothermal processing [13] . We could speculated that other iron oxides particles should be obtained if we tune some experimental conditions during "a mass transformation." Herein, nanoscale -Fe 2 O 3 was synthesized by using less than 3 nm or amorphous -Fe 2 O 3 as precursor in present of ethylene glycol.
However, if a trace of hydrazine hydrate was brought, the cubic phase [15] . If hydrazine hydrate is used at the same experiment conditions, the "intermediate" is maintained due to the strong reducing atmosphere, resulting in the final products of cubic Fe 3 O 4 (Figure 3(a) ); however, sizes of the products are still nanoscale (Figure 3(b) ). Therefore, we can speculate that the reducing atmosphere in the hydrothermal system determines the final phase of the iron oxides.
Finally, the magnetic characteristics of the prepared nanoparticles in the presence of magnetic field were measured using a vibrating sample magnetometer (VSM). Figure 4(a) shows the hysteresis loops at 300 K of as-prepared -Fe 2 O 3 precursor. It can be found that the saturation magnetization (Ms), remanent magnetization (Mr), and coercivity (Hc) are 13.6 emu/g, 0.016 emu/g and 92.6 Oe, respectively, showing soft ferromagnetic behaviour. Accordingly, the three values of as-synthesized -Fe 2 O 3 nanoparticles are 74.3 emu/g, 2.86 emu/g, and 43 Oe, respectively. The low remanent magnetization and high saturation magnetization simply indicate that the as-synthesized -Fe 2 O 3 nanoparticles are with good superparamagnetic property [9] .
Conclusions
Our work offers a facile method to prepare biocompatible nanoparticles. Herein, we adopted -Fe 2 O 3 as precursor to realize the growth of -Fe 2 O 3 nanoparticles, and Fe 3 O 4 nanoparticles can also be obtained only with the addition of a trace of hydrazine hydrate. The as-obtained samples are dispersed in water with a clean surface. This route provides a practical method to controllably prepare high quality iron oxides for biomedical application. The magnetic measurement by VSM revealed that the prepared iron oxides exhibit excellent superparamagnetic behavior.
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